New era for management of chronic hepatitis C virus using direct antiviral agents: A review-Reference-Cited by-同舟云学术

New era for management of chronic hepatitis C virus using direct antiviral agents: A review

Published:2015-05 Issue:3 Volume:6 Page:301-310
ISSN:2090-1232
Container-title:Journal of Advanced Research
language:en
Short-container-title:Journal of Advanced Research

Author:

Elbaz Tamer^ORCID,El-Kassas Mohamed,Esmat Gamal

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference104 articles.

1. Telaprevir in combination with peginterferon alfa-2a with or without ribavirin in the treatment of chronic hepatitis C. final results of the PROVE 2 study;Zeuzem;Hepatology,2008

2. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection;Hézode;N Engl J Med,2009

3. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection;McHutchison;N Engl J Med,2009

4. Telaprevir for previously treated chronic HCV infection;McHutchison;N Engl J Med,2010

5. Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New incidence or recurrence hepatocellular carcinoma (HCC) in genotype 4 hepatitis C virus treated with sofosbuvir/daclatasvir with or without ribavirin;F1000Research;2024-07-03

2. Impact of treating chronic hepatitis C with direct acting antivirals on health-related quality of life: a real-life Egyptian experience;Egyptian Liver Journal;2024-02-27

3. Global Hepatitis C Virus Elimination — Where Are We?;Current Hepatology Reports;2024-02-14

4. The crosstalk between directly acting antivirals and chronic HCV patients with different stages of renal affection: A multicenter study;Clinics and Research in Hepatology and Gastroenterology;2023-12

5. Hepatocellular carcinoma and hepatitis C virus treatments: The bold and the beautiful;Journal of Viral Hepatitis;2022-12-12